Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sauermann

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Biomed Research International|October 22, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and ImplicationsBrian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Biomed Research International|April 17, 2023
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Biomed Research International|October 22, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and ImplicationsBrian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Biomed Research International|April 17, 2023
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.
Pageof 5